Alabama
Birmingham; Clinical Research Consultants, Inc.
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Birmingham; Global Clinical Trial Link, LLC
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Huntsville; Tennessee Valley Pain Consultants
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Pinson; Deerfoot Internal Medicine
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Arizona
Casa Grande; Desert Oasis Cancer Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Tucson; Genova Clinical Research, Inc.
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
California
Duarte; City of Hope
Reducing Barriers to Pain and Fatigue Management
Fountain Valley; Pacific Coast Hematology/Oncology Medical Group, Inc.
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Gilroy; Office of Dr. Ronald Yanagihara
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Laguna Hills; Therapeutic Research Insitiute of Orange County
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Loma Linda; Center for Pain Management
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Los Angeles; UCLA
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
San Diego; San Diego Managed Care Group
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
San Diego; University of California San Diego Medical Center
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
Colorado
Littleton; Arapahoe Gastroenterology, PC
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Florida
Chiefland; Southeast Clinical Research
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Melbourne; Osler Medical Inc./Osler Clinical Research
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Plantation; Gold Coast Research LLC
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Tampa; University of Southern Florida
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
West Palm Beach; Palm Beach Research Center
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Winter Park; National Pain Research Institute, LLC
A Multi-Center Study to Evaluate the Safety and Efficacy an Investigational Medication for the Treatment of Breakthrough Cancer Pain
Georgia
Atlanta; PMI Health Research Group
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Decatur; Dekalb Pain Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Riverdale; Center of Hope for Cancer and Blood Disorders
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Idaho
Boise; Northwest Clinical Trials
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Illinois
Bloomington; Millennium Pain Cntr.
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Chicago; Pain & Rehabilitation Clinic of Chicago
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Springfield; Southern Illinois University School of Medicine
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Indiana
Indianapolis; Investigative Clinical Research of Indiana, LLC
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Kentucky
Lexington; Pain Treatment Center of the Bluegrass
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Louisiana
Baton Rouge; Gulf Coast Research
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
New Orleans; Louisiana Research Associates
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Maryland
Elkridge; Centennial Medical Group
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Hagerstown; Research Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Massachusetts
Boston; Brigham and Women's Hospital
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
Boston; BWH - Brigham and Women's Hospital
A Double Blind, Randomized, Placebo Controlled, Parallel Group Dose-Range Exploration Study of Sativex in Relieving Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy
Burlington; Lahey Clinic
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
Chestnut Hill; Brigham and Women's Hospital
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Fall River; St. Anne's Hospital
“A PIVOTAL STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF MR-GUIDED FOCUSED ULTRASOUND TREATMENT OF METASTATIC BONE TUMORS FOR THE PALLIATION OF PAIN IN PATIENTS WHO ARE NOT CANDIDATES FOR RADIATION THERAPY.”
Minnesota
Edina; MAPS Applied Research Center
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Missouri
Jefferson City; Capital Comprehensive Cancer Care Clinic
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Kansas City; St. Luke's Cancer Institute
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
St Peters; Midwest Pharmaceutical Research, Inc.
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
St. Louis; A & A Pain Institute
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Montana
Great Falls; Research Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
New Jersey
Ridgewood; Neurology Group of Bergen County, P.A.
Research study of an experimental pain medication for patients with pain related to cancer.
New Mexico
Albuquerque; Lovelace Scientific Resources, Inc.
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
New York
Toronto, Ontario; Toronto General Hospital
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
Great Neck; Long Island Gasronintestinal Research Group
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
New York; Cornell University
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
New York; Cornell University
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
North Carolina
Flat Rock; Four Seasons Hospice & Palliative Care
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Flat Rock; Four Seasons Hospice & Pallative Care
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Winston Salem; The Center for Clinical Research, LLC
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Winston-Salem; Center for Clinical Research
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Ohio
Akron; Summa Health System/ Cancer Research
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Canton; Gabrail Cancer Center
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Canton; Gabrail Cancer Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Cincinnati; Riverhills Healthcare Research Division
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Dayton; Dayton Science Institute
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Dover; Gabrail Cancer Center
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Oklahoma
Oklahoma City; Oklahoma Gynecologic Oncology
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Tulsa; Options Health Research
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Oregon
Medford; Medford Medical Clinic
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Pennsylvania
Philadelphia; Fox Chase Cancer Center
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
South Carolina
Anderson; Anderson Gastroenterology Associates, LLC
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Sumter; Office of Billy Clowney
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Tennessee
Chattanooga; ClinSearch
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Texas
Austin; Lone Star Oncology
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Houston; The Methodist Hospital Research Institute
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
Houston; Sightline Health
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
Utah
Salt Lake City; Huntsman Cancer Institute
Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY study)
Salt Lake City; Lifetree Clinical Research
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
Washington
Spokane; Spokane Internal Medicine
A dose escalation study of NKTR-118 in patients with opioid-induced constipation (OIC).
International
Toronto, Ontario, Canada; Toronto General Hospital
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
Tel Hashomer, Israel; Sheba Medical Center
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
Tel Hashomer, Israel; Sheba Medical Center
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
